Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MD · against 365 other Healthcare companies of similar size
Ranked #73 of 366 · scores higher than 78% of peers
Bars: peers in each 10-point band of the valuation score52 peers with a valuation score of 80–89, including MD · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | MD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 356 reported | 6.9% | 2.1% | 86% | 30% | |
| EBITDA yieldHigher is better · 364 reported | 10.0% | 4.5% | 82% | 50% | |
| Free cash flow yieldHigher is better · 181 reported | 9.2% | -0.2% | 91% | 20% | |
| Book yieldHigher is better · 356 reported | 36.3% | 32.7% | 55% | Context only |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score